Hrt Financial LP Cerus Corp Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.66 - $2.42 $155,935 - $227,327	-93,937 Reduced 82.86%	19,436 $36,000
Q4 2023 Feb 09, 2024	BUY	$1.25 - $2.35 $141,716 - $266,426	113,373 New	113,373 $244,000
Q4 2022 Feb 10, 2023	BUY	$3.38 - $4.22 $42,922 - $53,589	12,699 New	12,699 $46,000
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $925,876 - $1.35 Million	-192,490 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $804,839 - $1.07 Million	134,814 Added 233.74%	192,490 $1.31 Million
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $276,268 - $385,275	57,676 New	57,676 $351,000
Q2 2021 Aug 16, 2021	SELL	$5.35 - $6.35 $61,310 - $72,771	-11,460 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $65,092 - $90,190	11,460 New	11,460 $68,000
Q4 2020 Feb 16, 2021	SELL	$5.25 - $8.56 $82,288 - $134,169	-15,674 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$5.78 - $7.47 $90,595 - $117,084	15,674 New	15,674 $98,000

157

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $351M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.